Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion type Assertion NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_head.
- NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion wasGeneratedBy ECO_0000203 NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_provenance.
- NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion wasDerivedFrom befree-20140225 NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_provenance.
- NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion SIO_000772 23861247 NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_provenance.
- NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion evidence source_evidence_literature NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_provenance.
- NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183609.RAs0aldJut61Dz0aqU-NfHeDosHp3hX1Hnf0hcm-gHyJQ130_provenance.